Table 1.
Baseline characteristics.
| Variablea | N = 637 |
|---|---|
| Male | 384 (60.3%) |
| Age, years | 30.00 (30.00, 45.00) |
| Disease duration, years | 6.01 (2.78, 11.02) |
| BMI, kg/m2 | 24.40 (21.21, 27.55) |
| Smoking history | 208 (32.7%) |
| Concomitant medications | |
| Corticosteroids | 352 (55.3%) |
| 5-Aminosalicylic acid | 456 (71.6%) |
| Immunomodulators | 192 (30.1%) |
| History of anti-TNF exposure | 345 (54.2%) |
| History of vedolizumab exposure | 121 (19.0%) |
| Partial Mayo score | 6.00 (5.00, 7.00) |
| Endoscopic Mayo score | 3.00 (2.00, 3.00) |
| CRP, mg/l | 4.69 (1.62, 12.40) |
| FC, µg/g | 1486.00 (603.50, 2904.25) |
| FL, µg/ml | 202.79 (74.12, 443.82) |
aContinuous and categorical variables are presented as median (IQR) and frequency (%), respectively.